Lisinopril

Revision as of 13:10, 9 April 2014 by Ahmed Zaghw (talk | contribs)
Jump to navigation Jump to search


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2], Amr Marawan, M.D. [3]

Lisinopril

Lisinopril and Hydrochlorothiazide tablet

Overview

Lisinopril tablet is an angiontensin converting enzyme inhibitor drug that is FDA approved for the treatment of hypertension, heart failure, left ventricular dysfunction after myocardial infarction, diabetic nephropathy. Adverse reactions include hypotension, rash, hyperkalemia, disorder of taste, cough. hypotension, rash, hyperkalemia, disorder of taste, cough.

Category

Antihypertensive Agents, Angiotensin Converting Enzyme Inhibitors. Editor-In-Chief: C. Michael Gibson, M.S., M.D. [4]; Associate Editor(s)-in-Chief: Amr Marawan, M.D. [5]

For patient information about Lisinopril, click here.

Synonyms / Brand Names: LISINOPRIL®, ACERCOMP®, INHIBRIL®, LINOPRIL®, LISINOPRIL DIHYDRATE®, LISIPRIL®, LYSINOPRIL®, NOPERTEN®, PRESITEN®, PRINIVIL®, PRINZIDE®, RENACOR®, SINOPRIL®, ZESTRIL®

Overview

Lisinopril is a drug of the angiotensin-converting enzyme (ACE) inhibitor class used primarily in treatment of hypertension, congestive heart failure, and heart attacks, and also in preventing renal and retinal complications of diabetes. Its indications, contraindications and side effects are as those for all ACE inhibitors. Lisinopril was the third ACE inhibitor (after captopril and enalapril) and was introduced into therapy in the early 1990s. A number of properties distinguish it from other ACE inhibitors: It is hydrophilic, has a long half-life and tissue penetration, and is not metabolized by the liver.

Category

Antihypertensive Agents, ACE Inhibitors

References